(By Paige Twenter for Becker’s Hospital Review)
The infection antibiotic amoxicillin is in short supply among at least three drugmakers, according to the American Society of Health-System Pharmacists and Bloomberg.
As of Oct. 20, 14 of London-based Hikma Pharmaceuticals’ amoxicillin products and nine of Israel-based Teva Pharmaceuticals’ supply are part of the national shortage, according to the ASHP’s drug shortage website. Continue reading here…
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org